Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

Blake Emerson of UCLA Law breaks down the legal arguments and economic stakes as the Court hears arguments about Trump’s ...

(SNCR) on Tuesday reported net income of $5.8 million in its third quarter.

Dow Jones Top Financial Services Headlines at 4 PM ET: Apollo Invests $75 Billion in Quarter As Firm Continues to Grow Deal Capacity | Sequoia ... Apollo Invests $75 Billion in Quarter As Firm ...

Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...

The record dropped the same week that Pope John Paul II and Palestine leader Yasser Arafat came together for their historic ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why Kimberly-Clark was willing to buy a company with weakening sales and ...

Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...